---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-135660"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T07:56:11.755634+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bruker appoints QIAGEN CEO Thierry Bernard to Board of Directors

## Summary
- Thierry L. Bernard appointed to Bruker's Board effective April 1, 2026; board expanded to 12 directors.
- Bernard is CEO of QIAGEN N.V. (NYSE: QGEN), set to step down upon successor appointment; brings life-science tools expertise.
- He previously served 15 years at bioMérieux including Corporate VP Global Commercial Operations, Investor Relations, and Greater China.
- Bernard also sits on Neogen Corporation (NASDAQ: NEOG) board and chairs AdvaMedDx trade association.

## SEC filing metadata
- accession: 0001193125-26-135660
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000119312526135660/0001193125-26-135660-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000119312526135660/brkr-20260401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-135660
- JSON: https://secwatch.observer/filing/0001193125-26-135660.json
- Plain text: https://secwatch.observer/filing/0001193125-26-135660.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.